Skip to main content

NextGen Discovery Series – Sept. 13, 2023


The NextGen Precision Health Discovery Series provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities. The series consists of monthly lectures geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts. 

Information about this upcoming talk, including continuing education, is available below.

For questions about this event or any others in the Discovery Series, please reach out to Veronica Lemme at

“Lessons from Simons Foundation Programs in Autism Research”

Speaker: Kelsey Martin, M.D., Ph.D., Executive Vice President, SFARI, Simons Foundation Neuroscience Collaborations

Date: Wednesday, Sept. 13, 2023, Noon-1 p.m.

Location: Tom and Linda Atkins Family Seminar Room, Roy Blunt NextGen Precision Health building


This presentation will provide a history and overview of the Simons Foundation Autism Research Initiative (SFARI), the nation’s largest private funder of autism research. SFARI’s activities include convening, grantmaking and resource-building all aimed at increasing the understanding, diagnosis and treatment of autism spectrum. Dr. Martin will review advances made in elucidating the genetic architecture of autism spectrum disorder (ASD) and will provide examples of research that is beginning to provide insights into specific features of ASD. A focus of her talk will be on the power of community-participatory research, which brings the autism community together with autism researchers. 

About the SpeakerKelsey C. Martin

Kelsey C. Martin, M.D., Ph.D., is the executive vice president of the Simons Foundation Autism Research Initiative (SFARI) and the Simons Foundation Neuroscience Collaborations. She also is a professor of biological chemistry and psychiatry at UCLA, where her research lab studies the molecular and cell biology of long-term memory, with a focus on how experience alters gene expression to change connectivity between neurons. Dr. Martin served as dean of the David Geffen School of Medicine at UCLA from 2015-2021. She received her B.A. in English from Harvard University and her M.D. and Ph.D. at Yale University and did post-doctoral research training with Nobel Laureate Eric Kandel at Columbia University. Dr. Martin is a member of the American Academy of Arts and Sciences and the National Academy of Medicine.


Continuing Professional Education Credit

Successful Completion of this activity, which includes participating in the educational offering, participating in the evaluation process and completing the verification of attendance, enables the learner to satisfy the requirements for continuing education.

Nursing Contact Hours

University of Missouri Sinclair School of Nursing is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). 

1.0 contact hour may be awarded.


The University of Missouri-Columbia School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

The University of Missouri-Columbia School of Medicine designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Financial Relationships

Current ACCME and Midwest Multistate Division, ANCC rules state that participants in continuing education activities should be made aware of any relevant affiliation or financial interest in the previous 24 months that may affect the planning of an educational activity or a speaker’s presentation(s). Each planning committee member and speaker has been requested to complete a financial relationship reporting form for the NextGen Precision Health Discovery Series. No planning committee member or speaker has a relevant financial interest.